Trial Profile
Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Depression
- Focus Therapeutic Use
- 04 Jan 2021 Status changed from recruiting to completed.
- 03 Jan 2017 New trial record